DLH Holdings Corp. announced that it has been awarded a contract to continue operating the AIDS Clinical Trials Group’s (ACTG) Network Coordinating Center (NCC). ACTG, which is funded by the National Institutes of Health, is the world’s large and longest running HIV clinical trials network, conducting research to improve the treatment of HIV, its co-infections, and its comorbidities. The NCC collaborates with ACTG leadership to provide technical, scientific, and administrative support. DLH’s award under this contract has an estimated total value of up to $42 million (one base year and six option years). This contract is a sub award to DLH from the ACTG Leadership and Operations Center at the University of California, Los Angeles, which has been funded for the next seven years by NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and collaborating NIH institutes. ACTG was the first clinical trials network to focus on HIV and currently has sites in 15 countries. ACTG often carries out other epidemiological studies and, in 2020, implemented the ACTIV-2 study, a trial to identify effective treatments for early COVID-19.